Possible association of Guillain-Barré syndrome and hepatitis A vaccination.
We report a case of Guillain-Barré syndrome in a previously healthy child who received a hepatitis A vaccination (HAVRIX) 5 days before onset of symptoms. No other precipitating factor could be identified. The relevant literature is reviewed and discussed.
Blumenthal
Danith
D
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
Prais
Dario
D
Bron-Harlev
Efrat
E
Amir
Jacob
J
D002675:Child, Preschool; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D020275:Guillain-Barre Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy*; D006506:Hepatitis A / Q000517:prevention & control*; D022362:Hepatitis A Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D008297:Male; D012121:Respiration, Artificial; D018570:Risk Assessment; D012720:Severity of Illness Index; D014611:Vaccination / Q000009:adverse effects
D022362:Hepatitis A Vaccines; D016756:Immunoglobulins, Intravenous